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Abstract
The Plasmodium falciparum variant erythrocyte surface antigens known as PfEMP1, encoded by the var gene family, are thought to play a
crucial role in malaria pathogenesis because they mediate adhesion to host cells and immuno-modulation. Var genes have been divided into three
major groups (A, B and C) and two intermediate groups (B/A and B/C) on the basis of their genomic location and upstream sequence. We analysed
expressed sequence tags of the var gene DBL domain to investigate var gene transcription in relation to disease severity in Malian children. We
found that P. falciparum isolates from children with cerebral malaria (unrousable coma) predominantly transcribe var genes with DBL1-like
domains that are characteristic of Group A or B/A var genes. In contrast, isolates from children with equally high parasite burdens but no symptoms
or signs of severe malaria (hyperparasitaemia patients) predominantly transcribe var genes with DBL0-like domains that are characteristic of
the B and C-related var gene groups. These results suggest that var genes with DBL1-like domains (Group A or B/A) may be implicated in the
pathogenesis of cerebral malaria, while var genes with DBL0-like domains promote less virulent malaria infections.
© 2006 Elsevier B.V. All rights reserved.
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1. Introduction
Plasmodium falciparum malaria continues to exact a huge
toll on health and life throughout the tropics, predominantly
among young children in sub-Saharan Africa [1]. The clini-
cal manifestations of falciparum malaria differ markedly from
infection to infection; disease symptoms often remain mild, but
in some cases severe complications such as cerebral malaria,
severe malarial anaemia or respiratory distress develop [2].
The reasons why certain children develop life-threatening com-
Abbreviations: DBL, Duffy binding like; PfEMP1,P. falciparum erythrocyte
membrane protein one
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plications, while others are able to tolerate very high para-
site burdens without severe clinical symptoms remain unclear
[3].
Severe malaria has previously been associated with expres-
sion of a restricted and antigenically conserved subset of variant
erythrocyte surface antigens [4,5], suggesting that expression
of certain surface molecules may be associated with specific
disease manifestations. The major candidate molecules are the
PfEMP1 family (Plasmodium falciparum erythrocyte mem-
brane protein one) encoded by the var genes [6,7]. PfEMP1 is
thought to play a crucial role in host–parasite interaction because
it mediates adhesion to host cells to bring about sequestration and
immuno-modulation [3]. Each parasite has a repertoire of 50–60
var genes [8] and variant surface antigen expression is regularly
switched to avoid host recognition [9]. The extracellular portion
of PfEMP1 variants contains between two and seven cysteine-
rich domains known as Duffy-binding-like (DBL) domains [8].
0166-6851/$ – see front matter © 2006 Elsevier B.V. All rights reserved.
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DBL domains have been classified into five types, –, on the
basis of consensus motifs, plus a sixth heterogeneous group,
DBL-X [8,10]. The PfEMP1 DBL domain occurs towards
the N-terminus of the protein and is the most well-conserved
DBL domain. Two distinct types of DBL domain have been
described ( and 1), which differ in the number of conserved
cysteines and other hydrophobic residues [11]. For clarification
purposes we have here named the two distinct types of DBL
domain as DBL0 and DBL1.
On the basis of the full genomic sequence of the 3D7 P. fal-
ciparum clone, var genes have been classified into three major
groups (A, B and C) and two intermediate groups (B/A and B/C)
defined by the presence of one of three conserved 5′ upstream
sequences (UpsA, UpsB or UpsC), and by the gene’s position
and orientation within a chromosome (summarised in Table 1)
[8,12,13]. The Group A and B/A genes are larger and have a
more complex domain structure than the other groups [12]. All
of the Group A genes have a DBL1 type N-terminal domain,
and two out of four B/A genes have a hybrid DBL domain
with some DBL1-like features including the lower number
of conserved cysteine residues [11]. All of the 3D7 Group B,
B/C and C var genes have DBL0 N-terminal domains [11,12].
Amplification of expressed DBL sequence tags using degen-
erate primers [14] gives approximately 300–400 base pairs of
sequence that can be used to assign expressed var genes to
either DBL1-like sequences (Group A or B/A) or DBL0-like
sequences (Group B, C, B/C or B/A) on the basis of the num-
ber of conserved cysteine residues in the amplified tag sequence
(Table 1).
It has been suggested that the var gene groups may recom-
bine separately [12,13], and there is some evidence for different
functional properties between groups. Binding to the endothelial
receptor CD36 is a property of Group B, B/C and C genes but
not Group A genes [11], whereas binding to uninfected erythro-
cytes to mediate rosetting (a virulence-associated phenotype)
[15,16] is a property of the DBL1 domain of some Group A
genes [17,18]. A recent experiment showed up-regulation of
some Group A var genes in a P. falciparum laboratory clone
selected using semi-immune serum to express variant surface
antigens characteristic of severe malaria [19]. Taken together
these studies raise the hypothesis that parasite virulence and
clinical disease severity in malaria patients could be related to
transcription of particular var gene groups. Recent studies on
var gene transcription and malaria severity in clinical isolates
have, however, reached conflicting results [20–23]. This may be
because severe malaria encompasses a variety of clinical syn-
dromes (e.g. cerebral malaria, severe anaemia, respiratory dis-
tress, prostration) [2], and these syndromes may have different
underlying pathogenic mechanisms [3]. Significant associations
between var gene groups and clinical disease may be masked
unless strictly defined clinical groups are assessed along with
suitable control groups [24,25].
We aimed to investigate the hypothesis that parasite virulence
and clinical disease severity in African children are associated
with the transcription of distinct subsets of P. falciparum var
genes. We examined P. falciparum isolates from patients with
one of the commonest and most virulent forms of severe malaria,
cerebral malaria (unrousable coma), compared to isolates from
controls with equally high parasite burdens but non-virulent
disease (hyperparasitaemia patients). Our data show that P. fal-
ciparum isolates from cerebral malaria patients are significantly
more likely to transcribe var genes with DBL1-like domains
characteristic of Group A and B/A var genes than isolates from
patients with non-severe hyperparasitaemia, which predomi-
nantly transcribe var genes with DBL0-like domains.
2. Materials and methods
2.1. Sample collection and RNA extraction
The samples were collected as part of the Bandiagara Malaria
Project case-control study of severe malaria that has been
described in detail previously [26,27]. Blood samples were col-
lected from children with malaria after informed consent from
parents or guardians, and all protocols received institutional
review board approval. Blood samples were suspended in glyc-
erolyte after lymphocyte separation via density centrifugation
and frozen to −70 ◦C. A blood spot from each isolate was
made on 3 MM Whatman paper for genomic DNA extraction.
Frozen samples were shipped to Edinburgh where they were
thawed by standard methods and cultured for 8–24 h until the
parasites were a mixture of late ring stage and early pigmented-
trophozoite stage (morphologically equivalent to approximately
16–20 h post-invasion in a laboratory strain). This was done
in order to study parasite stages in which the full length var
mRNA is present [28], while avoiding the early ring stage,
when some authors claim multiple non-specific var transcrip-
tion occurs [29]. The cultured cells were solubilised in Tri-
zol and stored at −70 ◦C. RNA was extracted as described
[28].
Table 1
Characteristics of P. falciparum var gene groups
var gene
group
Upstream
sequence
Position Orientation (direction
of transcription)
No. of genes
in 3D7
No. of DBL
domains
DBL0/1 No. of cysteines
in amplified tag
A UpsA Subtelomeric Telomeric 10 2–5 DBL1 2
B/A UpsB Subtelomeric Centromeric 4 4–7 DBL1 or DBL0a 2 or 4
B UpsB Subtelomeric Centromeric 21 2–3 DBL0 4
B/C UpsB Central Telomeric 10 2–3 DBL0 4
C UpsC Central Telomeric 13 2–3 DBL0 4
a Two of the 3D7 Group B/A var genes (PFL0020w and MAL6P1.4) have a DBL0 domain and two (PF08 0140 and MAL6P1.316) have a hybrid DBL0/1
domain that is DBL0-like at the N-terminus but DBL1-like in the expressed sequence tag region (i.e. it has two rather than four conserved cysteine residues).
H.M. Kyriacou et al. / Molecular & Biochemical Parasitology 150 (2006) 211–218 213
2.2. DNA extraction and genotyping
DNA was extracted from blood spots on filter paper using
chelex-100 extraction [30]. The minimum number of genotypes
per isolate was estimated by genotyping PCR with primers to
MSP1 and MSP2 [31].
2.3. cDNA preparation
RNA was treated for 30 min at room temperature with
1.5 units DNAase (Gibco) to remove any contaminating
genomic (g) DNA. cDNA was prepared using Superscript First
Strand Synthesis System (Invitrogen) with random hexamers
according to manufacturers instructions.
2.4. RT-PCR
Reverse-transcriptase (RT)-PCR was used to amplify a region
of 300–400 bp of the var DBL domain using unbiased degen-
erate primers AF′ and BR [14,21]. These primers are capable
of amplifying the entire var gene repertoire of 3D7 apart from
the strain-transcending var2CSA gene implicated in malaria in
pregnancy [32] and the type 3 var genes that are of unknown
function. Amplification conditions were as described [14] with
a hot start (95 ◦C, 5 min) followed by 35 cycles of 95 ◦C, 20 s;
42 ◦C, 20 s; 60 ◦C, 1 min. Samples without RT were used in all
reactions to exclude gDNA contamination.
2.5. PCR for upstream regions
Upstream PCRs were carried out on gDNA using upstream
primers UpsA (5′-TAT TYH ATK TAT TAY ATT TGT TGT
A) UpsB (5′-GTT AGA ACA TTT AAA ATT ATA) and UpsC
(5′-AVA GAW ATA TGR TAG ATA YAG), based on sequences
from 3D7, and a gene-specific DBL primer for each isolate.
Amplification conditions were 35 cycles of 94 ◦C, 5 s; 46 ◦C,
15 s; 60 ◦C, 2 min. The upstream sequence of the predominant
var gene from nine isolates was studied. The remaining upstream
sequences were not studied due to lack of parasite material.
2.6. Cloning and sequencing
PCR and RT-PCR products were run on agarose gels and
extracted (Gel Extraction Kit, QIAGEN) then cloned (TA
cloning kit, Invitrogen), and used to transform One Shot TOP10F
competent cells (Invitrogen). Transformed cells were grown
overnight and individual white colonies were selected for cul-
ture. Plasmids were extracted from overnight cultures using a
miniprep kit (QIAGEN), and were sequenced using BigDye ter-
minator reaction mix (Applied Biosciences).
2.7. Sequence analysis
Sequences were analysed using Lasergene software (DNAS-
TAR Inc). Contigs were created with a minimum percentage
match of 95% to classify sequences for each isolate. Amino
acid sequences were aligned using MUSCLE [33] and the
alignment converted into a nucleotide alignment with Tranalign
(http://bioweb.pasteur.fr/docs/EMBOSS/tranalign.html)
2.8. Phylogenetic network
A phylogenetic network was generated rather than a tradi-
tional phylogenetic tree because var genes are subject to recom-
bination. The network allows visualisation of ambiguous and
conflicting signals in the dataset due to recombination or other
factors [34]. Splits computed from the data are represented as
parallel edges rather than single branches and the network pro-
vides an implicit representation of evolutionary history [34]. The
phylogenetic network was generated in SplitsTree 4.4 [34] using
the Neighbor-Net distances transformation [35] and equal angle
splits transformation [36].
3. Results
Twenty-six P. falciparum field isolates were obtained from a
vaccine trial site in Mali with intense seasonal transmission of P.
falciparum (up to 20–60 infected bites per person per month at
the peak of the July–December transmission season [37]). Blood
was obtained from children with cerebral malaria (unrousable
coma with a Blantyre coma score ≤2 and no other detectable
cause of coma), non-severe hyperparasitaemia (>500, 000 par-
asites per microlitre of blood but with no symptoms or signs
of severe disease) or uncomplicated malaria (fever and P. falci-
parum parasitaemia with no evidence of severe malaria or hyper-
parasitaemia). Hyperparasitaemia is generally considered to be
an indication of severe malaria using World Health Organisation
criteria [38]. However, African children with hyperparasitaemia
and no other symptoms or signs of severe disease have a very
low mortality rate, and hyperparasitaemia in sub-Saharan Africa
can thus be considered as a form of non-severe malaria [2,26].
There were no significant differences in patient age across
the three clinical categories (Table 2). The cerebral malaria
and hyperparasitaemia patients did not differ significantly in
parasitaemia, but the uncomplicated malaria patients had signif-
icantly lower parasitaemias than the other two groups (Table 2).
We therefore considered the hyperparasitaemia isolates to pro-
vide a better control group for the cerebral malaria isolates than
the uncomplicated malaria isolates, because the major differ-
ence between the cerebral and hyperparasitaemia isolates is in
parasite virulence and disease severity rather than parasite bur-
den. Parasite rosette frequency was significantly associated with
disease severity, as expected in isolates from Africa (Table 2)
[15,16]. Multiple genotypes were present in most isolates (range
1–5), and there was no significant difference in the number of
genotypes between the three clinical categories (Table 2).
The transcribed DBL var gene sequences from each iso-
late were amplified by reverse transcriptase-PCR using unbi-
ased degenerate primers [14]. The RT-PCR products were
cloned and 14–19 recombinant plasmids with var gene inserts
were sequenced per isolate. Identical sequences from the
same isolate were defined as isolate sequence a, b, c etc. in
decreasing order of abundance (GenBank accession numbers
DQ367086–DQ367226). The number of distinct DBL vargene
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Table 2
Summary of patient and parasite isolate details
Malaria disease category Age (months)
(mean ± S.D.)
Parasitaemia (%)
(mean ± S.D.)
Rosette frequencya (%)
(median:25th, 75th percentiles)
Genotypes
(mean:range)
Uncomplicated 45.8 ± 28.0 3.3 ± 1.5 8.0:0, 15.8 2.4 (1–4)
Hyperparasitaemia 42.5 ± 16.9 11.9 ± 3.9 9.5:0, 18.0 2.6 (1–4)
Cerebral malaria 35.2 ± 22.0 12.3 ± 6.3 22.0:19.8, 46.8 2.2 (1–5)
P values >0.45b 0.83 H:Cc, <0.001 U:C/H 0.03d >0.48e
a Percent of mature-stage infected erythrocytes that bind two or more uninfected erythrocytes.
b Uncomplicated: cerebral P = 0.46, uncomplicated: hyperparasitaemia P = 0.72, cerebral:hyperparasitaemia P = 0.68, Student’s t-test.
c H: hyperparasitaemia; C: cerebral malaria; U: uncomplicated malaria. Student’s t-test.
d Kruskal–Wallis test.
e Uncomplicated: cerebral P = 0.72, uncomplicated: hyperparasitaemia P = 0.72, cerebral:hyperparasitaemia P = 0.49, Student’s t-test.
sequences detected per isolate varied between 1 and 14, and
almost every isolate showed a predominant gene (Fig. 1). Iden-
tical or almost identical sequences from different isolates were
rare, indicating minimal overlap in var gene repertoires between
isolates (see Supplementary material for further details). There
was no significant difference in the number of distinct DBL
sequences per isolate detected in each clinical category (cere-
bral malaria: median 5, range 1–9; hyperparasitaemia: median
6.5, range 2–14; uncomplicated malaria: median 4, range 2–10,
P = 0.72, Kruskall–Wallis test). Further experiments to validate
the reproducibility of these data are shown in the Supplementary
material (Fig. S1).
There was a highly significant difference between clini-
cal categories in the percentage of var genes amplified that
were DBL1-like. 80.1% of the var gene sequences amplified
from the cerebral malaria isolates were DBL1-like, compared
to only 25.7% of the sequences from the hyperparasitaemia
isolates and 40.5% of the sequences from the uncomplicated
malaria patients (P < 0.001, Chi-square test, Fig. 1). If only the
predominant gene from each isolate was examined, a marked
difference remained between the cerebral malaria and hyper-
parasitaemia isolates (P = 0.013, Fishers Exact test, Fig. 2), but
not between any other group (uncomplicated versus hyperpar-
asitaemia, P = 0.294; uncomplicated versus cerebral, P = 0.131,
Fishers Exact test). There was a significant positive correlation
between the proportion of DBL1-like sequences and the rosette
frequency (Rho = 0.520,P = 0.009, Spearman Rank correlation).
The contrast between the var genes transcribed by the isolates
from cerebral malaria patients compared to hyperparasitaemia
patients was also demonstrated by mapping clinical categories
across a phylogenetic network of DBL sequence tags (Fig. 3).
A phylogenetic network was used rather than a traditional phy-
logenetic tree because var genes are subject to recombination,
a process that can generate conflicting signals in tree-building
and can be a significant source of error [34]. For reference, a
selection of DBL sequence tags from the three major Groups
A, B and C from the fully sequenced P. falciparum laboratory
clone 3D7 [8] were included, plus four 3D7 genes with interme-
diate characteristics (B/A or B/C). In the phylogenetic network
the sequences fell into two major clades (Fig. 3). All of the
sequences to the left of the dotted line are DBL0-like (i.e. they
contain four cysteine residues in the expressed sequence tag),
whereas all of the sequences to the right of the dotted line are
Fig. 1. Frequencies of distinct DBL tags in each isolate. The pie charts repre-
sent the relative number of different DBL var gene sequences detected in each
isolate by RT-PCR, cloning and analysis of 14–19 mini-prep clones per isolate.
The number of sections in each pie represents the number of distinct DBL tags
detected, and the size of each section represents the relative frequency of each
DBL tag. Bracketed numbers indicate the exact number of mini-prep clones
sequenced for each isolate. The sample name is in the top left corner of each box
and the rosette frequency (percentage of mature infected erythrocytes binding
two or more uninfected erythrocytes) in the bottom left corner. White segments
represent DBL1-like var genes (i.e. two conserved cysteine residues in the
amplified DBL tag) whereas grey segments represent DBL0-like var genes
(i.e. four conserved cysteine residues in the amplified DBL tag).
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Fig. 2. Alignment of DBL domains. A MUSCLE alignment of the predominant gene transcribed by P. falciparum isolates from cerebral malaria and hyperpara-
sitaemia patients. The second half of the expressed sequence tag is shown and the position of the residues that distinguish DBL0-like domains (cysteines present)
from DBL1-like domains (cysteines missing) are arrowed, and the cysteine residues are boxed. The predominant gene in 8/9 isolates from cerebral malaria patients
is of the DBL1-like type, whereas the predominant gene in 6/8 hyperparasitaemia isolates is of the DBL0-like type. This difference is significant by Fishers Exact
test (P = 0.013). Symbols: (*) indicates conserved residues; (:) indicates conservative substitution; (·) indicates semi-conservative substitution.
Fig. 3. Phylogenetic network showing relationships between var gene DBL sequence tags transcribed by P. falciparum isolates, generated using Neighbour-Net
[35]. Sequences transcribed by isolates from African children with cerebral malaria (CM, red), hyperparasitaemia (HYP, blue), and uncomplicated malaria (U, green)
are compared to a selection of var genes from the laboratory clone 3D7. For the 3D7 genes, the gene name is preceded by A, B, C, BA or BC to indicate the group
to which the gene belongs. The sequences fall into two major clades, with the DBL0-like sequences to the left of the dotted line and the DBL1-like sequences to
the right. For the predominant gene from nine of the Malian isolates, the var gene upstream region was determined by PCR and is indicated as a boxed letter.
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DBL1-like (containing two cysteine residues in the expressed
sequence tag) (Fig. 3). A phylogenetic network containing the
full repertoire of 3D7 var gene sequence tags plus the Malian
sequences was also generated and gave the same separation into
two distinct clades of DBL0-like and DBL1-like sequences
(data not shown due to the complexity of the figure. This is avail-
able from the authors on request). Sequences from the cerebral
malaria patients (red in Fig. 3) are significantly concentrated into
the “DBL1-like clade” (χ2 = 12.72 on 1 d.f., P < 0.001), while
sequences from the hyperparasitaemia patients (blue) are signif-
icantly concentrated in a “DBL0-like clade” (χ2 = 5.6 on 1 d.f.,
P < 0.025). Sequences from the uncomplicated malaria patients
(green) showed no bias in distribution between the two clades
(Fig. 3).
Further separation of the DBL expressed sequence tags
into the six sequence groups recently proposed by Bull et al.
[21] did not reveal any further differences between the three
disease categories (see Supplementary material, Fig. S2). Inves-
tigation of the var gene upstream regions for the predominant var
gene from nine isolates showed that four field isolate var genes
with DBL0-like domains had UpsB or UpsC upstream regions,
whereas four out of five var genes with DBL1-like domains
had UpsA-type upstream regions and the fifth (Hyp4A) had an
UpsB sequence linked to a hybrid DBL0/1 domain and was
therefore a Group B/A var gene (Fig. 3).
4. Discussion
The major finding of this study is that P. falciparum isolates
from Malian children with cerebral malaria (a virulent form
of disease) predominantly transcribe var genes with DBL1-
like domains that are characteristic of Group A or B/A var
genes, whereas isolates from patients with hyperparasitaemia
(a non-virulent form of disease) predominantly transcribe var
genes with DBL0-like domains. These results provide the first
firm evidence from P. falciparum clinical isolates to support
the hypothesis put forward previously that Group A var genes
(which all have DBL1 domains) could be implicated in the
pathogenesis of severe malaria in African children [19].
Previous studies on var gene transcription in clinical iso-
lates have given conflicting results. A role for var genes with
DBL1-like domains in the multi-organ failure type of severe
malaria that occurs in adults in low malaria transmission set-
tings was suggested by a study of 10 Brazilian isolates [20]. A
study in Papua New Guinea, however, showed upregulation of
Group B var genes in clinical disease (severe and uncompli-
cated) compared to asymptomatic infections [22]. The “severe
disease” patients in the Papua New Guinea study had a vari-
ety of different clinical syndromes, and strictly defined cerebral
malaria (Blantyre coma score ≤2) was not included. A recent
study from Tanzania also investigated a mixed group of severe
malaria patients and found increased abundance of both Groups
A and B var genes in severe compared to uncomplicated and
asymptomatic malaria patients [23]. Analysis of a sub-group
of seven patients with neurological alterations (Blantyre coma
score ≤3, therefore this group does not fulfill a strict defini-
tion of cerebral malaria) did suggest a trend towards increased
abundance of Group A var genes, but this was not statistically
significant [23]. A study of sequence diversity in Kenyan field
isolates did not find any association between var gene group and
disease manifestation, however only six isolates from assorted
severe malaria patients were studied, only one of whom had
cerebral malaria [21]. As pointed out previously, severe malaria
is a heterogeneous group of syndromes that may have different
underlying pathogenic mechanisms, therefore strict definitions
of disease are essential in studies addressing malaria pathogen-
esis [24]. Appropriate controls groups with equivalent parasite
burdens are also required [24,25], and the study reported here is
the first to investigate var gene transcription using isolates from
non-severe hyperparasitaemia patients as a control group rather
than uncomplicated malaria patients with low parasite burdens.
Although it remains possible that there are genuine geographi-
cal differences in the relationship between var gene transcription
and disease severity, we suggest that the reason why a clear pat-
tern emerged from the current study, even though the sample
numbers are not large, is because a strictly defined severe disease
syndrome (cerebral malaria) was investigated and a non-severe
malaria control group with equivalent parasite burdens (hyper-
parasitaemia) was used.
We also investigated vargene transcription in parasite isolates
from children with uncomplicated malaria and lower parasite
burdens that are equivalent to the control groups used in pre-
vious studies [20–23]. Isolates from these patients showed a
mixed pattern of var gene transcription with four out of nine
isolates transcribing mostly DBL1-like var genes, while five
out of nine isolates transcribed mostly DBL0-like var genes
(Figs. 1 and 3 and Fig. S2). This is consistent with the idea
that non-hyperparasitaemic uncomplicated malaria represents
an earlier stage in the natural history or pathogenesis pathway
of a malaria infection. At this stage, the host–parasite process
has progressed beyond asymptomatic infection and produced
symptoms, but it may yet diverge along several possible path-
ways ranging from spontaneous resolution to hyperparasitaemia,
cerebral malaria, other severe syndromes, and death. Our data
support the hypothesis that parasites expressing DBL1-like
var genes influence the direction of the disease process toward
cerebral malaria, presumably increasing the predilection for par-
asites to sequester and cause microvascular obstruction in the
brain. Other factors are likely to influence this process includ-
ing host genotype [39], and it is possible that parasite isolates
transcribing “cerebral malaria-type” DB1-like var genes may
fail to cause severe disease in some children because of host
genetic polymorphisms that can modify parasite virulence phe-
notypes [40].
This study and previous similar investigations [20–23] use
peripheral blood samples to examine P. falciparum var gene
transcription profiles in clinical isolates. One unusual feature
of malaria infection is that only immature ring stage para-
sites are found in the peripheral blood, whereas the mature
blood stage parasites (pigmented trophozoites and schizonts)
are sequestered in the microvasculature [3]. Therefore it is a
major concern in studies of this type whether the parasites in the
peripheral blood adequately represent the sequestered popula-
tion. Ideally studies aimed at examining the relationship between
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var gene transcription and particular disease syndromes would
examine sequestered parasites, however, these are only acces-
sible in post-mortem samples making such studies technically
and ethically difficult. Two recent studies from Malawi suggest
that the dominant parasite genotypes of sequestered parasites
are usually the same as those in the peripheral blood [41], and
that parasite genotypes in cerebral malaria patients are homoge-
neously distributed throughout the body (i.e. distinct genotypes
are not sequestered in the brain compared to elsewhere in the
body or the peripheral blood) [42]. Although these studies do not
shed light upon the question of whether the var gene profile of
peripheral blood parasites reflects that of sequestered ones, they
are consistent with the possibility that the peripheral blood pop-
ulation could adequately reflect the sequestered parasite mass.
Any difference in var gene transcription between peripheral and
sequestered parasite populations would be likely to confound a
clear picture of the relationship between var genes and disease
syndromes. The fact that such a clear pattern of var gene tran-
scription in isolates from cerebral malaria patients compared to
hyperparasitaemia patients did emerge from this study suggests
that such a confounding effect is not a major problem.
Can the differing virulence-associations of the DBL1-like
var genes compared to the DBL0-like var genes shown in this
study be explained by the known functions of the different var
gene groups? The only adhesion phenotype currently ascribed
to the DBL1 domain of some Group A or B/A var genes is
binding to complement receptor 1 on uninfected erythrocytes
to form rosettes ([17,18] and J.A. Rowe unpublished data). The
field isolate data reported here along with two previous studies
[21,22] supports a link between the transcription of var genes
with DBL1-like domains and high rosette frequencies. Roset-
ting is a parasite virulence-associated phenotype [15,16] that
is thought to contribute to malaria pathogenesis by enhancing
sequestration and microvascular obstruction [43]. The function
of rosetting is unknown, but it may be an immune evasion mech-
anism that promotes parasite growth and survival leading to
rapid high parasitaemia in vivo [44]. Whether var genes contain-
ing DBL1-like domains mediate other binding phenotypes, in
addition to rosetting, that promote virulence is unknown, and is
an important question requiring further research.
Var genes encoding PfEMP1 variants with DBL0 domains
(i.e. Group B, C, B/C and some B/A var genes), on the other
hand, have been shown to bind to the endothelial receptor CD36
[11], and this interaction is believed to lead to the sequestra-
tion of infected erythrocytes in non-vital tissues [45] (away
from brain endothelium, which does not express CD36 [46]).
Our finding that var genes with DBL0-like domains are pre-
dominantly transcribed in non-virulent infections is consistent
with this hypothesis. In addition, binding of infected erythro-
cytes to CD36 on dendritic cells leads to inhibition of dendritic
cell maturation and impairment of host immune-responsiveness
[47]. This immuno-modulatory effect of Group B and C var
genes could contribute to the lower virulence of malaria in the
hyperparasitaemia patients if, as has been suggested previously,
immuno-pathology contributes to the pathogenesis of severe
malaria [48]. Parasites from hyperparasitaemia patients have
also been shown to have lower in vitro multiplication rates than
parasites from patients in other disease categories [49], which
could also contribute to the lower virulence of these infections.
In conclusion, we have shown that var genes with DBL1-
like domains (characteristic of Group A and some B/A var
genes) are predominantly transcribed in P. falciparum isolates
from Malian cerebral malaria patients, whereas var genes with
DBL0-like domains are predominantly transcribed in isolates
from patients with a non-virulent form of disease (hyperpara-
sitaemia). These findings suggest fundamental differences in the
roles played by the different var genes groups in host–parasite
interaction that could be related to the contrasting cytoadhe-
sive and immuno-modulatory functions of the var gene groups.
Further research is required to examine the disease-associations,
functions and diversity of var gene subsets in different geograph-
ical areas, and we emphasise the importance of strict clinical
definitions and appropriate control groups in future work.
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